公司資料
Sanara MedTech 股價、新聞與催化劑
- 股票代碼:
- SMTI
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
34.00 USD (-0.44%)
收盤價
最後更新: 2026年8月17日
195M USD
市值
股價為何變動
As of Aug 17, 2026, SMTI closed down 0.44% at $34.00. No new same-company headline was identified in the current news window.
公司概覽
Surgical Wound and Tissue Repair
Sanara MedTech develops and commercializes products intended to improve surgical healing and reduce complications and healthcare costs.
Soft-Tissue Repair Portfolio
The company’s products address wound cleansing, infection management, extracellular matrix support, and tissue repair across surgical specialties.
Procedure-Based Commercial Model
Sanara sells through hospital and surgeon relationships, with revenue driven by procedure volumes, product adoption, and expansion of its direct commercial organization.
Technology Acquisition Strategy
The company supplements internal development with licensed and acquired technologies that can be distributed through its existing surgical channel.
未來催化劑
- Sanara MedTech’s catalysts are wound-care and surgical-product sales, along with continued execution in specialty care. It is a steady operating story, so the market will focus on adoption and margin discipline.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。